Logo-aim
Arch Iran Med. 2021;24(7): 556-567. doi: 10.34172/aim.2021.79

Review Article

Gastric Cancer in Iran: An Overview of Risk Factors and Preventive Measures

Elham Akbarpour 1 ORCID, Alireza Sadjadi 1 * ORCID, Mohammad H. Derakhshan 2 ORCID, Gholamreza Roshandel 3 ORCID, Masoomeh Alimohammadian 1

Cited by CrossRef: 10

1- Shayan N, Rahimi A, Özcebe H. Cancer prevalence, incidence, and mortality rates in Afghanistan in 2020: A review study. Cancer Reports. 2023;6(9) [Crossref]
2- Pourfarzi F, Rashidi M, Yazdanbod A, Nemati A, Dogaheh H, Faghfuri E, Gorgani F, Hosseini-Asl S, Zamani B, Pourfarzi S, Etemadi A, Shafighian F, Rezaei N, Poustchi H, Malekzadeh R, Sadjadi A. Effectiveness of long-term low-dose aspirin in the prevention of gastric cancer after Helicobacter pylori eradication: study design and rationale of Ardabil gastric cancer randomized placebo-controlled prevention trial (AGCPT). Trials. 2024;25(1) [Crossref]
3- Sadjadi A, Akbarpour E, Alimohammadian M, Masoudi S, Ghanbari R, Rajabi Pour Z, Mohmmad Akbari F, Jafari M, Feiz-sani A, Hakimi H, Siavooshi F, Massarrat S, Malekzadeh R. A Population-Based Cross-sectional Study on the Prevalence and Associated Risk Factors of Helicobacter pylori Infection in Rafsanjan, a Low Gastric Cancer Area in Southeast Iran. Middle East J Dig Dis. 2022;14(3):287 [Crossref]
4- Karimy M, Shilan A, Shakiba M, Farmanbar R, Mahdavi-Roshan M, Kasmaei P, Mehrabian F. The Effect of an Educational Intervention Based on the Health Belief Model (HBM) on Nutritional Performance Related to Gastric Cancer in Rural Women in Northern Regions of Iran. Ecology of Food and Nutrition. 2024;63(1):8 [Crossref]
5- Eslami O, Najafzadeh M, Shafiei M. The Agreement between Endoscopic and Histopathological Findings of Esophageal and Gastroduodenal Lesions and Its Relationship with Endoscopists’ Experience. Middle East J Dig Dis. 2023;15(4):293 [Crossref]
6- Yun W, Zhang L, Yang N, Cui Z, Jiang H, Ha M, Yu D, Zhao M, Zheng H. FAM64A aggravates proliferation, invasion, lipid droplet formation, and chemoresistance in gastric cancer: A biomarker for aggressiveness and a gene therapy target. Drug Development Research. 2023;84(7):1537 [Crossref]
7- Allehdan S, Hammad S, Alatrash R, Al-Jaberi T, Hushki A, Yacoub S, Dahoud M, Elobeid T, Tayyem R. Protective effect of dietary micronutrients on gastric cancer risk among Jordanians. Nutr Hosp. 2023; [Crossref]
8- Talari F, Bozorg A, Zeinali S, Zali M, Mohsenifar Z, Asadzadeh Aghdaei H, Baghaei K. Low incidence of microsatellite instability in gastric cancers and its association with the clinicopathological characteristics: a comparative study. Sci Rep. 2023;13(1) [Crossref]
9- Mohammadnezhad K, Sahebi M, Alatab S, Sadjadi A. Modeling Epidemiology Data with Machine Learning Technique to Detect Risk Factors for Gastric Cancer. J Gastrointest Canc. 2024;55(1):287 [Crossref]
10- Morgos D, Stefani C, Miricescu D, Greabu M, Stanciu S, Nica S, Stanescu-Spinu I, Balan D, Balcangiu-Stroescu A, Coculescu E, Georgescu D, Nica R. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer. IJMS. 2024;25(3):1848 [Crossref]
11- Eskandarion M, Eskandarieh S, Tutunchi S, Shakoori Farahani A, Shirkoohi R. Investigating the role of circulating tumor cells in gastric cancer: a comprehensive systematic review and meta-analysis. Clin Exp Med. 2024;24(1) [Crossref]

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.